Home » Topics » BioWorld Science

BioWorld Science
RSS

Affimed's IND for AFM-24 cleared for phase I/II study in EGFR-expressing cancers

Nov. 8, 2019

Targeting acquired immunity improves brain injury recovery

Nov. 8, 2019

C4 Therapeutics discovers new cereblon ligands for cancer

Nov. 8, 2019

The Medicines discloses new boronic acid-based antibacterials

Nov. 8, 2019

Merck & Co. synthesizes new IDO1 inhibitors

Nov. 8, 2019

Constellation Pharmaceuticals patents EZH2 inhibitors

Nov. 8, 2019

Masitinib reduces severe asthma exacerbation rate in phase III study

Nov. 8, 2019

Researchers divulge new compounds for malaria

Nov. 8, 2019

Supernus Pharmaceuticals provides data from phase III P301 study of SPN-810

Nov. 8, 2019

AAV encoding NUsc1 rescues memory in Alzheimer's disease model

Nov. 8, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...